Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Thrombosis Research|July 17, 2016
Prevalence of calreticulin exon 9 indel mutations in vascular risk patientsThomas Jaeger, Axel Muendlein, Jasmin Hodaie, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 26, 2011
Are AHSG polymorphisms directly associated with coronary atherosclerosis?Axel Muendlein, Nicole Stark, Philipp Rein, et al.
Oncology Research and Treatment|February 27, 2022
Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 InhibitorsThomas Decker, Matthias Bichler, Andrea Birtel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 7, 2007
Low serum adiponectin is independently associated with both the metabolic syndrome and angiographically determined coronary atherosclerosisChristoph H Saely, Lorenz Risch, Guenter Hoefle, et al.
Atherosclerosis|November 12, 2015
Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic controlDaniel M Mueller, Martina Allenspach, Alaa Othman, et al.
Molecular Biology Reports|October 16, 2023
Myricetin attenuates hypoxia-induced inflammation in human adipocytesKathrin Geiger, Axel Muendlein, Andreas Leiherer, et al.
Vascular Pharmacology|August 26, 2015
High plasma chemerin is associated with renal dysfunction and predictive for cardiovascular events - Insights from phenotype and genotype characterizationAndreas Leiherer, Axel Muendlein, Elena Kinz, et al.
Breast Cancer Research and Treatment|July 25, 2023
Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patientsAxel Muendlein, Christine Heinzle, Eva Maria Brandtner, et al.
Atherosclerosis|May 4, 2019
The novel adipokine CTRP1 is significantly associated with the incidence of major adverse cardiovascular eventsAxel Muendlein, Andreas Leiherer, Christoph Saely, et al.
Data in Brief|July 24, 2019
Data on the association between CTRP1 and future major adverse cardiovascular events in patients undergoing coronary angiographyAxel Muendlein, Andreas Leiherer, Christoph Saely, et al.
Pageof 9